Estela Paz-Artal Selected Research

T-Independent Antigens (Antigens, T Independent)

1/2022

Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Estela Paz-Artal Research Topics

Disease

12	COVID-19 04/2022 - 09/2020
9	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 06/2012
8	Thrombosis (Thrombus) 01/2017 - 01/2014
6	Infections 12/2021 - 09/2006
3	Virus Diseases (Viral Diseases) 09/2020 - 02/2016
2	Neoplasms (Cancer) 01/2022 - 12/2020
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 08/2015
2	Pneumonia (Pneumonitis) 04/2021 - 04/2021
2	Cytokine Release Syndrome 04/2021 - 04/2021
2	Opportunistic Infections (Opportunistic Infection) 05/2016 - 07/2014
2	Autoimmune Lymphoproliferative Syndrome 01/2016 - 08/2006
1	Common Variable Immunodeficiency 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Leukemia 01/2022
1	Post-Acute COVID-19 Syndrome 10/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Parasitemia 10/2020
1	Malaria 10/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	GATA2 Deficiency 01/2017
1	Mycoses (Diseases, Fungus) 03/2016
1	Chronic Renal Insufficiency 01/2016
1	Clostridium Infections 08/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 01/2014
1	Vascular Diseases (Vascular Disease) 12/2013
1	Hypoalbuminemia 06/2012
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2012
1	Stroke (Strokes) 06/2012
1	Atherosclerosis 06/2012
1	End Stage Liver Disease 08/2007
1	Tuberculosis (Tuberculoses) 09/2006
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 09/2006
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2005
1	Neutropenia 01/2003
1	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 01/2003

Drug/Important Bio-Agent (IBA)

10	Immunoglobulin A (IgA)IBA 11/2020 - 01/2003
7	AntibodiesIBA 12/2021 - 06/2012
6	Antiphospholipid AntibodiesIBA 01/2017 - 01/2014
3	tocilizumab (atlizumab)FDA Link 04/2022 - 04/2021
3	AntigensIBA 12/2021 - 09/2020
3	CytokinesIBA 09/2021 - 01/2021
3	Immunoglobulin G (IgG)IBA 10/2020 - 01/2003
3	Glycoproteins (Glycoprotein)IBA 01/2014 - 06/2012
2	VaccinesIBA 01/2022 - 01/2021
2	BNT162 VaccineIBA 12/2021 - 01/2021
2	Interleukin-2 (IL2)IBA 12/2021 - 01/2021
2	InterferonsIBA 12/2021 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 04/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
2	PerforinIBA 12/2020 - 09/2006
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2020 - 10/2009
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2017 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 05/2016 - 02/2016
1	Chimeric Antigen ReceptorsIBA 01/2022
1	T-Independent Antigens (Antigens, T Independent)IBA 01/2022
1	Neutralizing AntibodiesIBA 12/2021
1	SteroidsIBA 10/2021
1	HLA-DR Antigens (HLA-DR)IBA 09/2021
1	ChromatinIBA 09/2021
1	Interleukin-10 (Interleukin 10)IBA 09/2021
1	Methylprednisolone FDA LinkGeneric 04/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	daratumumabIBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	mesoglycanIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	EpitopesIBA 10/2020
1	Peptides (Polypeptides)IBA 09/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2020
1	GATA2 Transcription FactorIBA 01/2017
1	CreatinineIBA 01/2016
1	Caspase 10IBA 01/2016
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 07/2015
1	Complement System Proteins (Complement)IBA 06/2012
1	Fas Ligand Protein (Fas Ligand)IBA 08/2006
1	Amino Acids FDA Link 01/2005
1	Immunoglobulin M (IgM)IBA 01/2003
1	CD40 Ligand (CD40L)IBA 01/2003

Therapy/Procedure

9	Kidney Transplantation 01/2018 - 01/2014
6	Transplantation 12/2020 - 10/2009
5	Therapeutics 04/2022 - 04/2021
3	Liver Transplantation 01/2021 - 08/2007
2	Organ Transplantation 05/2016 - 03/2016
1	Critical Care (Surgical Intensive Care) 09/2021
1	Salvage Therapy 04/2021
1	Immunomodulation 04/2021
1	Cell Transplantation 06/2012
1	Catheters 06/2012